RBC Capital Maintains Sector Perform on Gilead Sciences, Lowers Price Target to $120

Benzinga Newsdesk www.benzinga.com Negative 85.9%

Neg 85.9% Neu 0% Pos 0%

RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and lowers the price target from $122 to $120.